Le SIDA au Ghana (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Detection and management of drug-resistant tuberculosis in HIV-infected patients in lower-income countries.

Identifieur interne : 000554 ( PubMed/Corpus ); précédent : 000553; suivant : 000555

Detection and management of drug-resistant tuberculosis in HIV-infected patients in lower-income countries.

Auteurs : M. Ballif ; V. Nhandu ; R. Wood ; J C Dusingize ; E J Carter ; C P Cortes ; C C Mcgowan ; L. Diero ; C. Graber ; L. Renner ; D. Hawerlander ; S. Kiertiburanakul ; Q T Du ; T R Sterling ; M. Egger ; L. Fenner

Source :

RBID : pubmed:25299866

English descriptors

Abstract

Drug resistance threatens tuberculosis (TB) control, particularly among human immunodeficiency virus (HIV) infected persons.

DOI: 10.5588/ijtld.14.0106
PubMed: 25299866

Links to Exploration step

pubmed:25299866

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Detection and management of drug-resistant tuberculosis in HIV-infected patients in lower-income countries.</title>
<author>
<name sortKey="Ballif, M" sort="Ballif, M" uniqKey="Ballif M" first="M" last="Ballif">M. Ballif</name>
<affiliation>
<nlm:affiliation>Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Nhandu, V" sort="Nhandu, V" uniqKey="Nhandu V" first="V" last="Nhandu">V. Nhandu</name>
<affiliation>
<nlm:affiliation>Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Wood, R" sort="Wood, R" uniqKey="Wood R" first="R" last="Wood">R. Wood</name>
<affiliation>
<nlm:affiliation>Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Dusingize, J C" sort="Dusingize, J C" uniqKey="Dusingize J" first="J C" last="Dusingize">J C Dusingize</name>
<affiliation>
<nlm:affiliation>Women's Equity in Access to Care & Treatment, Kigali, Rwanda.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Carter, E J" sort="Carter, E J" uniqKey="Carter E" first="E J" last="Carter">E J Carter</name>
<affiliation>
<nlm:affiliation>United States Agency for International Development Academic Model Providing Access to Healthcare, Eldoret, Kenya.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Cortes, C P" sort="Cortes, C P" uniqKey="Cortes C" first="C P" last="Cortes">C P Cortes</name>
<affiliation>
<nlm:affiliation>University of Chile School of Medicine, Santiago, Chile.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Mcgowan, C C" sort="Mcgowan, C C" uniqKey="Mcgowan C" first="C C" last="Mcgowan">C C Mcgowan</name>
<affiliation>
<nlm:affiliation>Vanderbilt University School of Medicine, Nashville, Tennessee, USA.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Diero, L" sort="Diero, L" uniqKey="Diero L" first="L" last="Diero">L. Diero</name>
<affiliation>
<nlm:affiliation>United States Agency for International Development Academic Model Providing Access to Healthcare, Eldoret, Kenya.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Graber, C" sort="Graber, C" uniqKey="Graber C" first="C" last="Graber">C. Graber</name>
<affiliation>
<nlm:affiliation>Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Renner, L" sort="Renner, L" uniqKey="Renner L" first="L" last="Renner">L. Renner</name>
<affiliation>
<nlm:affiliation>University of Ghana Medical School, Accra, Ghana.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Hawerlander, D" sort="Hawerlander, D" uniqKey="Hawerlander D" first="D" last="Hawerlander">D. Hawerlander</name>
<affiliation>
<nlm:affiliation>Centre Intégré de Recherches Biocliniques, Abidjan, Côte d'Ivoire.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Kiertiburanakul, S" sort="Kiertiburanakul, S" uniqKey="Kiertiburanakul S" first="S" last="Kiertiburanakul">S. Kiertiburanakul</name>
<affiliation>
<nlm:affiliation>Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand; Children's Hospital, Ho Chi Minh City, Viet Nam.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Du, Q T" sort="Du, Q T" uniqKey="Du Q" first="Q T" last="Du">Q T Du</name>
<affiliation>
<nlm:affiliation>Swiss Tropical and Public Health Institute, University of Basel, Basel, Switzerland.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Sterling, T R" sort="Sterling, T R" uniqKey="Sterling T" first="T R" last="Sterling">T R Sterling</name>
<affiliation>
<nlm:affiliation>Vanderbilt University School of Medicine, Nashville, Tennessee, USA.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Egger, M" sort="Egger, M" uniqKey="Egger M" first="M" last="Egger">M. Egger</name>
<affiliation>
<nlm:affiliation>Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Fenner, L" sort="Fenner, L" uniqKey="Fenner L" first="L" last="Fenner">L. Fenner</name>
<affiliation>
<nlm:affiliation>Swiss Tropical and Public Health Institute, University of Basel, Basel, Switzerland.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:25299866</idno>
<idno type="pmid">25299866</idno>
<idno type="doi">10.5588/ijtld.14.0106</idno>
<idno type="wicri:Area/PubMed/Corpus">000554</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000554</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Detection and management of drug-resistant tuberculosis in HIV-infected patients in lower-income countries.</title>
<author>
<name sortKey="Ballif, M" sort="Ballif, M" uniqKey="Ballif M" first="M" last="Ballif">M. Ballif</name>
<affiliation>
<nlm:affiliation>Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Nhandu, V" sort="Nhandu, V" uniqKey="Nhandu V" first="V" last="Nhandu">V. Nhandu</name>
<affiliation>
<nlm:affiliation>Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Wood, R" sort="Wood, R" uniqKey="Wood R" first="R" last="Wood">R. Wood</name>
<affiliation>
<nlm:affiliation>Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Dusingize, J C" sort="Dusingize, J C" uniqKey="Dusingize J" first="J C" last="Dusingize">J C Dusingize</name>
<affiliation>
<nlm:affiliation>Women's Equity in Access to Care & Treatment, Kigali, Rwanda.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Carter, E J" sort="Carter, E J" uniqKey="Carter E" first="E J" last="Carter">E J Carter</name>
<affiliation>
<nlm:affiliation>United States Agency for International Development Academic Model Providing Access to Healthcare, Eldoret, Kenya.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Cortes, C P" sort="Cortes, C P" uniqKey="Cortes C" first="C P" last="Cortes">C P Cortes</name>
<affiliation>
<nlm:affiliation>University of Chile School of Medicine, Santiago, Chile.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Mcgowan, C C" sort="Mcgowan, C C" uniqKey="Mcgowan C" first="C C" last="Mcgowan">C C Mcgowan</name>
<affiliation>
<nlm:affiliation>Vanderbilt University School of Medicine, Nashville, Tennessee, USA.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Diero, L" sort="Diero, L" uniqKey="Diero L" first="L" last="Diero">L. Diero</name>
<affiliation>
<nlm:affiliation>United States Agency for International Development Academic Model Providing Access to Healthcare, Eldoret, Kenya.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Graber, C" sort="Graber, C" uniqKey="Graber C" first="C" last="Graber">C. Graber</name>
<affiliation>
<nlm:affiliation>Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Renner, L" sort="Renner, L" uniqKey="Renner L" first="L" last="Renner">L. Renner</name>
<affiliation>
<nlm:affiliation>University of Ghana Medical School, Accra, Ghana.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Hawerlander, D" sort="Hawerlander, D" uniqKey="Hawerlander D" first="D" last="Hawerlander">D. Hawerlander</name>
<affiliation>
<nlm:affiliation>Centre Intégré de Recherches Biocliniques, Abidjan, Côte d'Ivoire.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Kiertiburanakul, S" sort="Kiertiburanakul, S" uniqKey="Kiertiburanakul S" first="S" last="Kiertiburanakul">S. Kiertiburanakul</name>
<affiliation>
<nlm:affiliation>Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand; Children's Hospital, Ho Chi Minh City, Viet Nam.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Du, Q T" sort="Du, Q T" uniqKey="Du Q" first="Q T" last="Du">Q T Du</name>
<affiliation>
<nlm:affiliation>Swiss Tropical and Public Health Institute, University of Basel, Basel, Switzerland.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Sterling, T R" sort="Sterling, T R" uniqKey="Sterling T" first="T R" last="Sterling">T R Sterling</name>
<affiliation>
<nlm:affiliation>Vanderbilt University School of Medicine, Nashville, Tennessee, USA.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Egger, M" sort="Egger, M" uniqKey="Egger M" first="M" last="Egger">M. Egger</name>
<affiliation>
<nlm:affiliation>Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Fenner, L" sort="Fenner, L" uniqKey="Fenner L" first="L" last="Fenner">L. Fenner</name>
<affiliation>
<nlm:affiliation>Swiss Tropical and Public Health Institute, University of Basel, Basel, Switzerland.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series>
<title level="j">The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease</title>
<idno type="eISSN">1815-7920</idno>
<imprint>
<date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adult</term>
<term>Africa (epidemiology)</term>
<term>Anti-HIV Agents (administration & dosage)</term>
<term>Anti-HIV Agents (therapeutic use)</term>
<term>Antitubercular Agents (supply & distribution)</term>
<term>Antitubercular Agents (therapeutic use)</term>
<term>Asia (epidemiology)</term>
<term>Developing Countries</term>
<term>Directly Observed Therapy</term>
<term>Female</term>
<term>HIV Infections (drug therapy)</term>
<term>HIV Infections (epidemiology)</term>
<term>Humans</term>
<term>Latin America (epidemiology)</term>
<term>Male</term>
<term>Microbial Sensitivity Tests</term>
<term>Surveys and Questionnaires</term>
<term>Tuberculosis, Multidrug-Resistant (diagnosis)</term>
<term>Tuberculosis, Multidrug-Resistant (drug therapy)</term>
<term>Tuberculosis, Multidrug-Resistant (epidemiology)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en">
<term>Anti-HIV Agents</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en">
<term>Africa</term>
<term>Asia</term>
<term>Latin America</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="supply & distribution" xml:lang="en">
<term>Antitubercular Agents</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Anti-HIV Agents</term>
<term>Antitubercular Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en">
<term>Tuberculosis, Multidrug-Resistant</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>HIV Infections</term>
<term>Tuberculosis, Multidrug-Resistant</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>HIV Infections</term>
<term>Tuberculosis, Multidrug-Resistant</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adult</term>
<term>Developing Countries</term>
<term>Directly Observed Therapy</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Microbial Sensitivity Tests</term>
<term>Surveys and Questionnaires</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Drug resistance threatens tuberculosis (TB) control, particularly among human immunodeficiency virus (HIV) infected persons.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">25299866</PMID>
<DateCreated>
<Year>2014</Year>
<Month>10</Month>
<Day>10</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>06</Month>
<Day>12</Day>
</DateCompleted>
<DateRevised>
<Year>2017</Year>
<Month>02</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1815-7920</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>18</Volume>
<Issue>11</Issue>
<PubDate>
<Year>2014</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease</Title>
<ISOAbbreviation>Int. J. Tuberc. Lung Dis.</ISOAbbreviation>
</Journal>
<ArticleTitle>Detection and management of drug-resistant tuberculosis in HIV-infected patients in lower-income countries.</ArticleTitle>
<Pagination>
<MedlinePgn>1327-36</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.5588/ijtld.14.0106</ELocationID>
<Abstract>
<AbstractText Label="SETTING" NlmCategory="METHODS">Drug resistance threatens tuberculosis (TB) control, particularly among human immunodeficiency virus (HIV) infected persons.</AbstractText>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To describe practices in the prevention and management of drug-resistant TB under antiretroviral therapy (ART) programs in lower-income countries.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">We used online questionnaires to collect program-level data on 47 ART programs in Southern Africa (n = 14), East Africa (n = 8), West Africa (n = 7), Central Africa (n = 5), Latin America (n = 7) and the Asia-Pacific (n = 6 programs) in 2012. Patient-level data were collected on 1002 adult TB patients seen at 40 of the participating ART programs.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Phenotypic drug susceptibility testing (DST) was available in 36 (77%) ART programs, but was only used for 22% of all TB patients. Molecular DST was available in 33 (70%) programs and was used in 23% of all TB patients. Twenty ART programs (43%) provided directly observed therapy (DOT) during the entire course of treatment, 16 (34%) during the intensive phase only, and 11 (23%) did not follow DOT. Fourteen (30%) ART programs reported no access to second-line anti-tuberculosis regimens; 18 (38%) reported TB drug shortages.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Capacity to diagnose and treat drug-resistant TB was limited across ART programs in lower-income countries. DOT was not always implemented and drug supplies were regularly interrupted, which may contribute to the global emergence of drug resistance.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ballif</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nhandu</LastName>
<ForeName>V</ForeName>
<Initials>V</Initials>
<AffiliationInfo>
<Affiliation>Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wood</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dusingize</LastName>
<ForeName>J C</ForeName>
<Initials>JC</Initials>
<AffiliationInfo>
<Affiliation>Women's Equity in Access to Care & Treatment, Kigali, Rwanda.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Carter</LastName>
<ForeName>E J</ForeName>
<Initials>EJ</Initials>
<AffiliationInfo>
<Affiliation>United States Agency for International Development Academic Model Providing Access to Healthcare, Eldoret, Kenya.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cortes</LastName>
<ForeName>C P</ForeName>
<Initials>CP</Initials>
<AffiliationInfo>
<Affiliation>University of Chile School of Medicine, Santiago, Chile.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>McGowan</LastName>
<ForeName>C C</ForeName>
<Initials>CC</Initials>
<AffiliationInfo>
<Affiliation>Vanderbilt University School of Medicine, Nashville, Tennessee, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Diero</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>United States Agency for International Development Academic Model Providing Access to Healthcare, Eldoret, Kenya.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Graber</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Renner</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>University of Ghana Medical School, Accra, Ghana.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hawerlander</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Centre Intégré de Recherches Biocliniques, Abidjan, Côte d'Ivoire.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kiertiburanakul</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand; Children's Hospital, Ho Chi Minh City, Viet Nam.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Du</LastName>
<ForeName>Q T</ForeName>
<Initials>QT</Initials>
<AffiliationInfo>
<Affiliation>Swiss Tropical and Public Health Institute, University of Basel, Basel, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sterling</LastName>
<ForeName>T R</ForeName>
<Initials>TR</Initials>
<AffiliationInfo>
<Affiliation>Vanderbilt University School of Medicine, Nashville, Tennessee, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Egger</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fenner</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Swiss Tropical and Public Health Institute, University of Basel, Basel, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<CollectiveName>International epidemiological Databases to Evaluate AIDS (IeDEA)</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>U01AI069924</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U01 AI096299</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U01 AI069923</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U01AI069907</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U01AI069911</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U01A096299</GrantID>
<Agency>PHS HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U01 AI069911</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U01AI069919</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U01 AI069919</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U01 AI069907</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U01AI069923</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U01 AI069924</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>France</Country>
<MedlineTA>Int J Tuberc Lung Dis</MedlineTA>
<NlmUniqueID>9706389</NlmUniqueID>
<ISSNLinking>1027-3719</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D019380">Anti-HIV Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000995">Antitubercular Agents</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>J Biomed Inform. 2009 Apr;42(2):377-81</RefSource>
<PMID Version="1">18929686</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2013;8(10):e77697</RefSource>
<PMID Version="1">24147059</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Tuberc Lung Dis. 2010 Mar;14(3):253-4</RefSource>
<PMID Version="1">20132609</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Diagn Ther. 2011 Aug 1;15(4):189-94</RefSource>
<PMID Version="1">21913741</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet. 2010 May 22;375(9728):1830-43</RefSource>
<PMID Version="1">20488523</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Kathmandu Univ Med J (KUMJ). 2010 Jan-Mar;8(29):116-25</RefSource>
<PMID Version="1">21209520</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Pediatric Infect Dis Soc. 2015 Mar;4(1):30-8</RefSource>
<PMID Version="1">26407355</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Future Microbiol. 2011 Sep;6(9):1067-82</RefSource>
<PMID Version="1">21958145</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Infect Dis. 2012 May 15;205 Suppl 2:S228-40</RefSource>
<PMID Version="1">22476720</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arch Intern Med. 2003 May 12;163(9):1009-21</RefSource>
<PMID Version="1">12742798</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Infect Dis. 2007 Aug 15;196 Suppl 1:S86-107</RefSource>
<PMID Version="1">17624830</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet. 2009 May 30;373(9678):1861-73</RefSource>
<PMID Version="1">19375159</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Bull World Health Organ. 2012 Feb 1;90(2):111-119D</RefSource>
<PMID Version="1">22423162</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet Infect Dis. 2013 Jun;13(6):529-39</RefSource>
<PMID Version="1">23531391</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur Respir J. 2011 Sep;38(3):516-28</RefSource>
<PMID Version="1">21828024</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Microbiol Rev. 2011 Apr;24(2):351-76</RefSource>
<PMID Version="1">21482729</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Infect Dis. 2013 Feb;56(4):503-8</RefSource>
<PMID Version="1">23090928</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Opin HIV AIDS. 2009 Jul;4(4):325-33</RefSource>
<PMID Version="1">19532072</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Opin Pulm Med. 2011 May;17(3):134-41</RefSource>
<PMID Version="1">21415753</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Manag Med. 2002;16(4-5):371-400</RefSource>
<PMID Version="1">12463651</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Tuberc Lung Dis. 2011 May;15(5):620-7</RefSource>
<PMID Version="1">21756512</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Bull World Health Organ. 2012 Oct 1;90(10):739-747A</RefSource>
<PMID Version="1">23109741</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000349" MajorTopicYN="N" Type="Geographic">Africa</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D019380" MajorTopicYN="N">Anti-HIV Agents</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000995" MajorTopicYN="N">Antitubercular Agents</DescriptorName>
<QualifierName UI="Q000600" MajorTopicYN="N">supply & distribution</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001208" MajorTopicYN="N" Type="Geographic">Asia</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003906" MajorTopicYN="N">Developing Countries</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D023801" MajorTopicYN="N">Directly Observed Therapy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007843" MajorTopicYN="N" Type="Geographic">Latin America</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008826" MajorTopicYN="N">Microbial Sensitivity Tests</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018088" MajorTopicYN="N">Tuberculosis, Multidrug-Resistant</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">NIHMS658986</OtherID>
<OtherID Source="NLM">PMC4323497</OtherID>
<InvestigatorList>
<Investigator ValidYN="Y">
<LastName>Ajayi</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Anastos</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ballif</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bashi</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bishai</LastName>
<ForeName>W</ForeName>
<Initials>W</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Boulle</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Braitstein</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Carriquiry</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Carter</LastName>
<ForeName>J E</ForeName>
<Initials>JE</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Cegielski</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Chimbetete</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Conrad</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Cortes</LastName>
<ForeName>C P</ForeName>
<Initials>CP</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Davies</LastName>
<ForeName>M-A</ForeName>
<Initials>MA</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Diero</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Duda</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Durier</LastName>
<ForeName>N</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Dusingize</LastName>
<ForeName>J C</ForeName>
<Initials>JC</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Egger</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Eboua</LastName>
<ForeName>T F</ForeName>
<Initials>TF</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Fenner</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Gasser</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Geng</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Hardwicke</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Hoffmann</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Huebner</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kancheya</LastName>
<ForeName>N</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kiertiburanakul</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kim</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Lameck</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Leroy</LastName>
<ForeName>V</ForeName>
<Initials>V</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Lewden</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Lindegren</LastName>
<ForeName>M L</ForeName>
<Initials>ML</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Mandalakas</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Maskew</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>McKaig</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Mofenson</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Mpoudi- Etame</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Okwara</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Phiri</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Prasitsuebsai</LastName>
<ForeName>W</ForeName>
<Initials>W</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Petit</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Prozesky</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Reid</LastName>
<ForeName>S E</ForeName>
<Initials>SE</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Renner</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Reubenson</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sohn</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sterling</LastName>
<ForeName>T R</ForeName>
<Initials>TR</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Vo</LastName>
<ForeName>Q</ForeName>
<Initials>Q</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Walker</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Wehbe</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Wejse</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Wester</LastName>
<ForeName>W</ForeName>
<Initials>W</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Williams</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Wood</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Wools-Kaloustian</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Yao</LastName>
<ForeName>Z</ForeName>
<Initials>Z</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Yunihastuti</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Zhang</LastName>
<ForeName>F J</ForeName>
<Initials>FJ</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Zhao</LastName>
<ForeName>H X</ForeName>
<Initials>HX</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Han</LastName>
<ForeName>N</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Merati</LastName>
<ForeName>T P</ForeName>
<Initials>TP</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Wirawan</LastName>
<ForeName>D N</ForeName>
<Initials>DN</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Yuliana</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ditangco</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Uy</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bantique</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Phanuphak</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ruxrungtham</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Avihingsanon</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Mengthaisong</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kiertiburanakul</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sungkanuparph</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sanmeema</LastName>
<ForeName>N</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Chaiwarith</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sirisanthana</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kotarathititum</LastName>
<ForeName>W</ForeName>
<Initials>W</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Pham</LastName>
<ForeName>T T</ForeName>
<Initials>TT</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Cuong</LastName>
<ForeName>D D</ForeName>
<Initials>DD</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ha</LastName>
<ForeName>H L</ForeName>
<Initials>HL</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Nguyen</LastName>
<ForeName>V K</ForeName>
<Initials>VK</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bui</LastName>
<ForeName>V H</ForeName>
<Initials>VH</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Cao</LastName>
<ForeName>T T</ForeName>
<Initials>TT</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sohn</LastName>
<ForeName>A H</ForeName>
<Initials>AH</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Durier</LastName>
<ForeName>N</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Petersen</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Cooper</LastName>
<ForeName>D A</ForeName>
<Initials>DA</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Law</LastName>
<ForeName>M G</ForeName>
<Initials>MG</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Jiamsakul</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Boettiger</LastName>
<ForeName>D C</ForeName>
<Initials>DC</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Wati</LastName>
<ForeName>D K</ForeName>
<Initials>DK</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Atmikasari</LastName>
<ForeName>L P P</ForeName>
<Initials>LP</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Malino</LastName>
<ForeName>I Y</ForeName>
<Initials>IY</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Nallusamy</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Chan</LastName>
<ForeName>K C</ForeName>
<Initials>KC</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Lumbiganon</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kosalaraksa</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Tharnprisan</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Udomphanit</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Chokephaibulkit</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Lapphra</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Phongsamart</LastName>
<ForeName>W</ForeName>
<Initials>W</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Wittawatmongkol</LastName>
<ForeName>O</ForeName>
<Initials>O</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Dung</LastName>
<ForeName>K T K</ForeName>
<Initials>KT</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Lam</LastName>
<ForeName>N V</ForeName>
<Initials>NV</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>An</LastName>
<ForeName>P N</ForeName>
<Initials>PN</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Loan</LastName>
<ForeName>N T</ForeName>
<Initials>NT</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Truong</LastName>
<ForeName>H K</ForeName>
<Initials>HK</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Du</LastName>
<ForeName>T Q</ForeName>
<Initials>TQ</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Chau</LastName>
<ForeName>N H</ForeName>
<Initials>NH</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Do</LastName>
<ForeName>C V</ForeName>
<Initials>CV</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ha</LastName>
<ForeName>M T</ForeName>
<Initials>MT</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sohn</LastName>
<ForeName>A H</ForeName>
<Initials>AH</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Durier</LastName>
<ForeName>N</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Nipathakosol</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Cooper</LastName>
<ForeName>D A</ForeName>
<Initials>DA</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Law</LastName>
<ForeName>M G</ForeName>
<Initials>MG</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kariminia</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Dusingize</LastName>
<ForeName>J C</ForeName>
<Initials>JC</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Mutimura</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Gitembagara</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Anastos</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Tatwangire</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Izabelle</LastName>
<ForeName>I</ForeName>
<Initials>I</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Niyongabo</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Twizere</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Baramperanye</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Edmonds</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Yotebieng</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Azinyue</LastName>
<ForeName>I</ForeName>
<Initials>I</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ayangma</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Yiannoutsos</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ayaya</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bukusi</LastName>
<ForeName>E A</ForeName>
<Initials>EA</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Lewis-Kulzer</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Somi</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Lyamuya</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ngonyani</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ssali</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ssemuwemba</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Mwebesa</LastName>
<ForeName>B B</ForeName>
<Initials>BB</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kambugu</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Hermans</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Nalugoda</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Jjingo</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Chimbetete</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Dickinsonn</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Eley</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Fritz</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Garone</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Giddy</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Hoffmann</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>MacPhail</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Moultrie</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ndirangu</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Pestilli</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Phiri</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Prozesky</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Rabie</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Stringer</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Technau</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Wood</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Egger</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Graber</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kaeser</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Keiser</LastName>
<ForeName>O</ForeName>
<Initials>O</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Boulle</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Cornell</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Davies</LastName>
<ForeName>M-A</ForeName>
<Initials>MA</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Maxwell</LastName>
<ForeName>N</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Zannou</LastName>
<ForeName>D M</ForeName>
<Initials>DM</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ahouada</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Akakpo</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ahomadegbé</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bashi</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Gougounon-Houéto</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Azon-Kouanou</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Houngbé</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sehonou</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Koumakäı</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Alihonou</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>d'Almeida</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Hodonou</LastName>
<ForeName>I</ForeName>
<Initials>I</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Hounhoui</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sagbo</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Tossa-Bagnan</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Adjide</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Drabo</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bognounou</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Dienderé</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Traore</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Zoungrana</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Zerbo</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sawadogo</LastName>
<ForeName>A B</ForeName>
<Initials>AB</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Zoungrana</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Héma</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Soré</LastName>
<ForeName>I</ForeName>
<Initials>I</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bado</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Tapsoba</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName></LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kouéta</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ouedraogo</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ouédraogo</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Hiembo</LastName>
<ForeName>W</ForeName>
<Initials>W</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Gansonré</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Messou</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Gnokoro</LastName>
<ForeName>J C</ForeName>
<Initials>JC</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Koné</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kouakou</LastName>
<ForeName>G M</ForeName>
<Initials>GM</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bosse</LastName>
<ForeName>C A</ForeName>
<Initials>CA</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Brou</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Assi</LastName>
<ForeName>A I</ForeName>
<Initials>AI</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Chenal</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Hawerlander</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Soppi</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Minga</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Yoboue</LastName>
<ForeName>J-M</ForeName>
<Initials>JM</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Eholié</LastName>
<ForeName>S P</ForeName>
<Initials>SP</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Amego</LastName>
<ForeName>M D N</ForeName>
<Initials>MD</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Andavi</LastName>
<ForeName>V</ForeName>
<Initials>V</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Diallo</LastName>
<ForeName>Z</ForeName>
<Initials>Z</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ello</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Tanon</LastName>
<ForeName>A K</ForeName>
<Initials>AK</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Koule</LastName>
<ForeName>S O</ForeName>
<Initials>SO</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Anzan</LastName>
<ForeName>K C</ForeName>
<Initials>KC</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Guehi</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Aka</LastName>
<ForeName>E A</ForeName>
<Initials>EA</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Issouf</LastName>
<ForeName>K L</ForeName>
<Initials>KL</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kouakou</LastName>
<ForeName>J-C</ForeName>
<Initials>JC</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>N'Gbeche</LastName>
<ForeName>M-S</ForeName>
<Initials>MS</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Pety</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Avit- Edi</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kouakou</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Moh</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Yao</LastName>
<ForeName>V A</ForeName>
<Initials>VA</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Folquet</LastName>
<ForeName>M A</ForeName>
<Initials>MA</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Dainguy</LastName>
<ForeName>M-E</ForeName>
<Initials>ME</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kouakou</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Méa- Assande</LastName>
<ForeName>V T</ForeName>
<Initials>VT</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Oka-Berete</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Zobo</LastName>
<ForeName>N</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Acquah</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kokora</LastName>
<ForeName>M-B</ForeName>
<Initials>MB</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Eboua</LastName>
<ForeName>T F</ForeName>
<Initials>TF</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Timité -Konan</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Diecket Ahoussou</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Assouan</LastName>
<ForeName>J K</ForeName>
<Initials>JK</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sami</LastName>
<ForeName>M F</ForeName>
<Initials>MF</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kouadio</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Renner</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Goka</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Welbeck</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sackey</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Owiafe</LastName>
<ForeName>S N</ForeName>
<Initials>SN</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Wejse</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Da Silva</LastName>
<ForeName>Z J</ForeName>
<Initials>ZJ</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Paulo</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Rodrigues</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>da Silva</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Medina</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Oliviera-Souto</LastName>
<ForeName>I</ForeName>
<Initials>I</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Østergaard</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Laursen</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sodemann</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Aaby</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Fomsgaard</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Erikstrup</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Eugen-Olsen</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Mäýga</LastName>
<ForeName>M Y</ForeName>
<Initials>MY</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Diakité</LastName>
<ForeName>F F</ForeName>
<Initials>FF</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kalle</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Katile</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Traore</LastName>
<ForeName>H A</ForeName>
<Initials>HA</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Minta</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Cissé</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Dembeél</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Doumbia</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Fomba</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kaya</LastName>
<ForeName>A S</ForeName>
<Initials>AS</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Traoré</LastName>
<ForeName>A M</ForeName>
<Initials>AM</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Traoré</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Toure</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Dicko</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sylla</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Berthé</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Traoré</LastName>
<ForeName>H C</ForeName>
<Initials>HC</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Köýta</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Koné</LastName>
<ForeName>N</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>N'Diaye</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Coulibaly</LastName>
<ForeName>S T</ForeName>
<Initials>ST</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Traoré</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Traoré</LastName>
<ForeName>N</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Charurat</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ajayi</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Alim</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Dapiap</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Igbinoba</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Benson</LastName>
<ForeName>O</ForeName>
<Initials>O</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Adebamowo</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>James</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Osakede</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Olasode</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Seydi</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sow</LastName>
<ForeName>P S</ForeName>
<Initials>PS</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Diop</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Manga</LastName>
<ForeName>N M</ForeName>
<Initials>NM</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Tine</LastName>
<ForeName>J M</ForeName>
<Initials>JM</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bassabi</LastName>
<ForeName>C C</ForeName>
<Initials>CC</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sy</LastName>
<ForeName>H S</ForeName>
<Initials>HS</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ba</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Diagne</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Dior</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Faye</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Gueye</LastName>
<ForeName>R D</ForeName>
<Initials>RD</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Mbaye</LastName>
<ForeName>A D</ForeName>
<Initials>AD</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Albert</LastName>
<ForeName>C H</ForeName>
<Initials>CH</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Patassi</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kotosso</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kariyare</LastName>
<ForeName>B G</ForeName>
<Initials>BG</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Gbadamassi</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Komi</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Mensah-Zukong</LastName>
<ForeName>K E</ForeName>
<Initials>KE</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Pakpame</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Lawson-Evi</LastName>
<ForeName>A Koko</ForeName>
<Initials>AK</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Atakouma</LastName>
<ForeName>Y</ForeName>
<Initials>Y</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Takassi</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Djeha</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ephoévi-gah</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Djibril</LastName>
<ForeName>S El-Hadj</ForeName>
<Initials>Sel-H</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Dabis</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bissagnene</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Arrive</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Coffie</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ekouevi</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Jaquet</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Leroy</LastName>
<ForeName>V</ForeName>
<Initials>V</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Lewden</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sasco</LastName>
<ForeName>A J</ForeName>
<Initials>AJ</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Amani</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Azani</LastName>
<ForeName>J-C</ForeName>
<Initials>JC</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Balestre</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bessekon</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bohossou</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Gilbert</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Karcher</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Gonsan</LastName>
<ForeName>J M</ForeName>
<Initials>JM</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Carrou</LastName>
<ForeName>J Le</ForeName>
<Initials>JL</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Lenaud</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Nchot</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Malateste</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Yao</LastName>
<ForeName>A R</ForeName>
<Initials>AR</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Siloue</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Clouet</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Dosso</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Doring</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kouakou</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Rabourdin</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Rivenc</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Anglaret</LastName>
<ForeName>X</ForeName>
<Initials>X</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ba</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Essanin</LastName>
<ForeName>J B</ForeName>
<Initials>JB</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ciaranello</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Datte</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Desmonde</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Elvis</LastName>
<ForeName>J-S</ForeName>
<Initials>JS</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Gottlieb</LastName>
<ForeName>G S</ForeName>
<Initials>GS</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>GHoro</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kangah</LastName>
<ForeName>S N</ForeName>
<Initials>SN</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Malvy</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Meless</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Mounkaila- Harouna</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ndondoki</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Shiboski</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Tchounga</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Thiébaut</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Wandeler</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>McGowan</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Cahn</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Gotuzzo</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Grinsztejn</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Pape</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Padgett</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Madero</LastName>
<ForeName>J S</ForeName>
<Initials>JS</Initials>
</Investigator>
</InvestigatorList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2014</Year>
<Month>10</Month>
<Day>10</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2014</Year>
<Month>10</Month>
<Day>10</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2015</Year>
<Month>6</Month>
<Day>13</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">25299866</ArticleId>
<ArticleId IdType="doi">10.5588/ijtld.14.0106</ArticleId>
<ArticleId IdType="pmc">PMC4323497</ArticleId>
<ArticleId IdType="mid">NIHMS658986</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000554 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000554 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    SidaGhanaV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:25299866
   |texte=   Detection and management of drug-resistant tuberculosis in HIV-infected patients in lower-income countries.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:25299866" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a SidaGhanaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Tue Nov 7 18:07:38 2017. Site generation: Tue Mar 5 15:01:57 2024